Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix, Synamatix

Premium
CombiMatrix said this week that it has updated its Influenza-Detection System, to include 2,000 new sequences recently released by the Influenza Genome Sequencing Project.
 
Version 4.1 of the system consists of its Influenza A Microarray, ElectraSense reader, and sample-preparation kit. CMBX has sold the system since 2005.
 

 
Malaysian bioinformatics firm Synamatix this week launched SXOligosearch, a software tool that allows users of high-throughput applications to process, analyze, and integrate data from both microarrays and next-generation sequencers.
 
SXOligosearch is designed to map short sequences such as reads from the Illumina Genome Analyzer or oligonucleotide microarray probes, the company said. It is also able to handle low-quality reads containing any number of mismatches, insertions, or deletions with high accuracy.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.